読み込み中
Canton Strategic Holdings Inc., which was formerly known as Tharimmune, Inc. until its name change in February 2026, focuses on two primary areas. The company is committed to promoting the institutional integration of blockchain technology and fostering the digitization of financial markets, primarily by leveraging Canton Coin and offering support to the Canton network. In addition to its blockchain initiatives, the company is also deeply involved in pharmaceutical research and development. Its pipeline includes GV104, a buccal film technology designed to address respiratory and/or nervous system depression in military personnel and chemical incident responders, which has already finished its Phase 1 trial. Another significant project is GV023, an oral version of infliximab, engineered to resolve the key inconvenience of the standard intravenous treatment by eliminating the need for recurring infusions. Established in 2017, Canton Strategic Holdings Inc. is headquartered in Red Bank, New Jersey.
前日終値
$2.11
+$0.03 · +1.44%
日中の時刻はETです。市場データは遅延する場合があります。
Canton Strategic Holdings Inc., which was formerly known as Tharimmune, Inc. until its name change in February 2026, focuses on two primary areas. The company is committed to promoting the institutional integration of blockchain technology and fostering the digitization of financial markets, primarily by leveraging Canton Coin and offering support to the Canton network. In addition to its blockchain initiatives, the company is also deeply involved in pharmaceutical research and development. Its pipeline includes GV104, a buccal film technology designed to address respiratory and/or nervous system depression in military personnel and chemical incident responders, which has already finished its Phase 1 trial. Another significant project is GV023, an oral version of infliximab, engineered to resolve the key inconvenience of the standard intravenous treatment by eliminating the need for recurring infusions. Established in 2017, Canton Strategic Holdings Inc. is headquartered in Red Bank, New Jersey.
日中レンジ
現在 $2.11
52週レンジ
現在 $2.11
日中の時刻はETです。市場データは遅延する場合があります。
GoAI スコア
売り
バリュエーション
27
割高
センチメント
53
まちまち
リスク
72
高リスク
モメンタム
21
弱含み
GoAIの詳細リサーチ
詳しい根拠、カタリスト、リスクを確認できます。
Canton Strategic Holdings Inc., which was formerly known as Tharimmune, Inc. until its name change in February 2026, focuses on two primary areas. The company is committed to promoting the institutional integration of blockchain technology and fostering the digitization of financial markets, primarily by leveraging Canton Coin and offering support to the Canton network. In addition to its blockchain initiatives, the company is also deeply involved in pharmaceutical research and development. Its pipeline includes GV104, a buccal film technology designed to address respiratory and/or nervous system depression in military personnel and chemical incident responders, which has already finished its Phase 1 trial. Another significant project is GV023, an oral version of infliximab, engineered to resolve the key inconvenience of the standard intravenous treatment by eliminating the need for recurring infusions. Established in 2017, Canton Strategic Holdings Inc. is headquartered in Red Bank, New Jersey.
日中レンジ
現在 $2.11
52週レンジ
現在 $2.11
営業利益
純利益
| 指標（USD） | 2025年度 | 2024年度 | 2023年度 | 2022年度 | 2021年度 |
|---|---|---|---|---|---|
| 研究開発 | 307.4万 USD | 639.21万 USD | 355.96万 USD | 227.84万 USD | 184.28万 USD |
| 販売・一般管理 | 1703.21万 USD | 604.17万 USD | 589.56万 USD | 460.35万 USD | 136.52万 USD |
| 営業費用 | 2010.61万 USD | 1243.38万 USD | 945.52万 USD | 688.19万 USD | 320.8万 USD |
| 受取利息 | 4.14万 USD | 24.99万 USD | 15.26万 USD | — | — |
| 支払利息 | 2.83万 USD | 1.37万 USD | 1.65万 USD | 159.12万 USD | 83.13万 USD |
| 減価償却費と償却費 | 2201.04万 USD | — | 945.52万 USD | 156.9万 USD | — |
| 営業利益 | −2010.61万 USD | −1243.38万 USD | −945.52万 USD | −688.19万 USD | −320.8万 USD |
| 純利益 | −3591.63万 USD | −1219.76万 USD | −931.91万 USD | −847.32万 USD | −220.66万 USD |
会社概要が更新されました 2026年10月11日.
直近の発表実績
直近の発表実績
この株式へのエクスポージャーを報告している上場投資信託です。
Vanguard Morningstar Total Stock Market ETFVTI499.03万0.00%2.3兆 USD0.03%$381.94+0.63%
iShares Russell 2000 ETFIWM318.73万0.00%787.4億 USD0.19%$278.94+0.49%
Vanguard Extended Market ETFVXF181.87万0.00%954億 USD0.05%$235+0.80%
ARK Blockchain & Fintech Innovation ETFARKF88.48万0.10%7.01億 USD0.75%$47.59+2.52%
Vanguard Russell 2000 ETFVTWO57.77万0.00%180億 USD0.06%$112.66+0.50%
iShares Micro-Cap ETFIWC42.76万0.03%13.17億 USD0.60%$183+0.11%
Vanguard Russell 2000 Value ETFVTWV9.37万0.01%14億 USD0.06%$185.81-0.13%
iShares Blockchain and Tech ETFIBLC7.87万0.10%7852.05万 USD0.47%$42.985-0.03%Vanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 ETFIWMVanguard Extended Market ETFVXFARK Blockchain & Fintech Innovation ETFARKFVanguard Russell 2000 ETFVTWOiShares Micro-Cap ETFIWCVanguard Russell 2000 Value ETFVTWViShares Blockchain and Tech ETFIBLCAIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。
